PDGFRA and gastrointestinal stromal tumor: The ones (5–7.5% of all GIST) with KIT/PDGFRA wild-types are then sub-classified depending on the functionality of the succinate dehydrogenase enzyme (SDH B/C/D), which might be deficient due to mutation or epigenetic regulation.